Cargando…

Re-implantation after insufficient primary 125-i permanent prostate brachytherapy

INTRODUCTION: We describe five patients receiving a re-implantation (RI) after post-operative dosimetry of the primary 125-I permanent prostate brachytherapy (BT) for prostate cancer revealed an insufficient dose coverage. MATERIALS AND METHODS: Five out of 222 consecutive patients treated (from Mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Putora, Paul Martin, Plasswilm, Ludwig, Seelentag, Wolf, Schiefer, Johann, Markart, Patrick, Schmid, Hans-Peter, Engeler, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851561/ https://www.ncbi.nlm.nih.gov/pubmed/23915390 http://dx.doi.org/10.1186/1748-717X-8-194

Ejemplares similares

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
por: Maletzki, Philipp, et al.
Publicado: (2018)

Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
por: Njomnang Soh, Patrice, et al.
Publicado: (2013)

Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
por: Ruge, Maximilian I, et al.
Publicado: (2012)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
por: Du, E, et al.
Publicado: (2017)

Benefits of a dual sagittal crystal transducer for ultrasound imaging during I-125 seed implantation for permanent prostate brachytherapy
por: Kaljouw, Emmie, et al.
Publicado: (2012)

The phylogeny of permanent prostate brachytherapy
por: Aronowitz, Jesse N., et al.
Publicado: (2013)

Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia
por: Muraki, Koichiro, et al.
Publicado: (2021)

A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse
por: Peters, Samuel, et al.
Publicado: (2014)

An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma
por: Shen, Xinying, et al.
Publicado: (2015)

Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources
por: Commission Internationale de Protection contre les Radiations
Publicado: (2005)

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial
por: Abt, Dominik, et al.
Publicado: (2018)

Correlations between intraplan and postplan parameters in I-125 permanent prostate brachytherapy using loose seeds or linked seeds
por: Ito, Fumitaka, et al.
Publicado: (2022)

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Compensability index for compensation radiotherapy after treatment interruptions
por: Putora, Paul Martin, et al.
Publicado: (2012)

Combination of Permanent Interstitial (125)I-Seed Brachytherapy and Surgery for the Treatment of Large Hepatocellular Carcinoma
por: Li, Xiaogang, et al.
Publicado: (2017)

Spontaneous healing of rectal penetration by SpaceOAR(®) hydrogel insertion during permanent iodine-125 implant brachytherapy: A case report
por: Iinuma, Koji, et al.
Publicado: (2019)

Acute urinary morbidity after a permanent (125)I implantation for localized prostate cancer
por: Ohga, Saiji, et al.
Publicado: (2014)

Comparison between preoperative and real-time intraoperative planning (125)I permanent prostate brachytherapy: long-term clinical biochemical outcome
por: Matzkin, Haim, et al.
Publicado: (2013)

Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
por: Walsh, Amanda, et al.
Publicado: (2019)

Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience
por: Panje, Cedric, et al.
Publicado: (2015)

Pre-plan parameters predict post-implant D(90) ≥ 140 Gy for (125)I permanent prostate implants
por: Alexander, Jes, et al.
Publicado: (2014)

Comparison of permanent (125)I seeds implants with two different techniques in 500 cases of prostate cancer
por: Guinot, Jose Luis, et al.
Publicado: (2015)

Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study
por: Nakano, Masahiro, et al.
Publicado: (2015)

Inverse planning optimization for hybrid prostate permanent‐seed implant brachytherapy plans using two source strengths
por: Cunha, J. Adam M., et al.
Publicado: (2010)

Radiotherapy or Surgery? Comparative, Qualitative Assessment of Online Patient Education Materials on Prostate Cancer
por: Vu, Erwin, et al.
Publicado: (2021)

Effect of constipation on dosimetry after permanent seed brachytherapy for prostate cancer
por: Otón, L. Fernando, et al.
Publicado: (2015)

A comparative evaluation of loading times and exposures for permanent prostate brachytherapy
por: Bice, W. S., et al.
Publicado: (2002)

Automated estimation of number of implanted iodine-125 seeds for prostate brachytherapy based on two-view analysis of pelvic radiographs
por: Kawata, Hidemichi, et al.
Publicado: (2012)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
por: Makino, Tomoyuki, et al.
Publicado: (2016)

Clinical features of prostate-specific antigen bounce after (125)I brachytherapy for prostate cancer
por: Kubo, Katsumaro, et al.
Publicado: (2018)

Bioevaluation of (125)I Ocu-Prosta seeds for application in prostate cancer brachytherapy
por: Mukherjee, Archana, et al.
Publicado: (2014)

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
por: Harada, Kosaku, et al.
Publicado: (2012)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer—A Review
por: Süveg, Krisztian, et al.
Publicado: (2022)

Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy
por: Moorrees, Joshua, et al.
Publicado: (2012)

Comparison of pre-implant treatment planning and post-implant dosimetry in I-125 spinal metastases brachytherapy
por: Chen, Guohua, et al.
Publicado: (2020)

Permanent Iodine-125 Seed Implantation for the Treatment of Nonresectable Retroperitoneal Malignant Tumors
por: Li, Qingchun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4kde11t2k7su9pfs1ms802iau9